Risk minimization measures

Scientific Name	Brand name	Approval Date	Last Update	Details
Caplacizumab	Cablivi	2021-02-01		View
Teriflunomide	Axyla	2021-02-01	2023-11-16	View
Eliglustat	Cerdelga	2021-01-12		View
Rivaroxaban	Banoriv	2021-01-12		View
Pegcetacoplan	Empaveli	2021-01-12		View
Canakinumab	Ilaris	2021-01-10	2023-07-30	View
Rivaroxaban	Xarelto	2021-01-09		View
Rituximab	Truxima	2021-01-02		View
Imiglucerase	Cerezyme	2021-01-01		View
Baricitinib	Olumiant	2021-01-01	2023-03-07	View